FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2829754639> ?p ?o ?g. }

• W2829754639 abstract "The incidence and severity of tuberculosis chemotherapy toxicity is poorly characterised. We used data available from patients in the REMoxTB trial to provide an assessment of the risks associated with the standard regimen and two experimental regimens containing moxifloxacin.All grade 3 & 4 adverse events (AEs) and their relationship to treatment for patients who had taken at least one dose of therapy in the REMoxTB clinical trial were recorded. Univariable logistic regression was used to test the relationship of baseline characteristics to the incidence of grade 3 & 4 AEs and significant characteristics (p < 0.10) were incorporated into a multivariable model. The timing of AEs during therapy was analysed in standard therapy and the experimental arms. Logistic regression was used to investigate the relationship between AEs (total and related-only) and microbiological cure on treatment.In the standard therapy arm 57 (8.9%) of 639 patients experienced ≥1 related AEs with 80 of the total 113 related events (70.8%) occurring in the intensive phase of treatment. Both four-month experimental arms (isoniazid arm with moxifloxacin substituted for ethambutol & ethambutol arm with moxifloxacin substituted for isoniazid) had a lower total of related grade 3 & 4 AEs than standard therapy (63 & 65 vs 113 AEs). Female gender (adjOR 1.97, 95% CI 0.91-1.83) and HIV-positive status (adjOR 3.33, 95% CI 1.55-7.14) were significantly associated with experiencing ≥1 related AE (p < 0.05) on standard therapy. The most common adverse events on standard therapy related to hepatobiliary, musculoskeletal and metabolic disorders. Patients who experienced ≥1 related AE were more likely to fail treatment or relapse (adjOR 3.11, 95% CI 1.59-6.10, p < 0.001).Most AEs considered related to standard therapy occurred in the intensive phase of treatment with female patients and HIV-positive patients demonstrating a significantly higher risk of AEs during treatment. Almost a tenth of standard therapy patients had a significant side effect, whereas both experimental arms recorded a lower incidence of toxicity. That patients with one or more AE are more likely to fail treatment suggests that treatment outcomes could be improved by identifying such patients through targeted monitoring." @default.
• W2829754639 created "2018-07-19" @default.
• W2829754639 creator A5000612367 @default.
• W2829754639 creator A5001004624 @default.
• W2829754639 creator A5005030069 @default.
• W2829754639 creator A5007168352 @default.
• W2829754639 creator A5011647772 @default.
• W2829754639 creator A5014029759 @default.
• W2829754639 creator A5015001907 @default.
• W2829754639 creator A5019513252 @default.
• W2829754639 creator A5019623012 @default.
• W2829754639 creator A5028037547 @default.
• W2829754639 creator A5028536003 @default.
• W2829754639 creator A5046472072 @default.
• W2829754639 creator A5051379518 @default.
• W2829754639 creator A5062598432 @default.
• W2829754639 creator A5063041747 @default.
• W2829754639 creator A5066806599 @default.
• W2829754639 creator A5090307232 @default.
• W2829754639 date "2018-07-11" @default.
• W2829754639 modified "2023-10-16" @default.
• W2829754639 title "Toxicity associated with tuberculosis chemotherapy in the REMoxTB study" @default.
• W2829754639 cites W1514251952 @default.
• W2829754639 cites W1518970375 @default.
• W2829754639 cites W1524448761 @default.
• W2829754639 cites W1539980468 @default.
• W2829754639 cites W161728136 @default.
• W2829754639 cites W1915965026 @default.
• W2829754639 cites W1984796878 @default.
• W2829754639 cites W1985993793 @default.
• W2829754639 cites W1987118166 @default.
• W2829754639 cites W1996194136 @default.
• W2829754639 cites W1997433600 @default.
• W2829754639 cites W2003268107 @default.
• W2829754639 cites W2024416030 @default.
• W2829754639 cites W2040454566 @default.
• W2829754639 cites W2054425245 @default.
• W2829754639 cites W2063618125 @default.
• W2829754639 cites W2091050540 @default.
• W2829754639 cites W2099045802 @default.
• W2829754639 cites W2108042393 @default.
• W2829754639 cites W2109028417 @default.
• W2829754639 cites W2111276287 @default.
• W2829754639 cites W2114394851 @default.
• W2829754639 cites W2129047823 @default.
• W2829754639 cites W2134655561 @default.
• W2829754639 cites W2141859976 @default.
• W2829754639 cites W2143942591 @default.
• W2829754639 cites W2154396724 @default.
• W2829754639 cites W2166822423 @default.
• W2829754639 cites W2204791478 @default.
• W2829754639 cites W2331439827 @default.
• W2829754639 cites W2419519060 @default.
• W2829754639 cites W2466617788 @default.
• W2829754639 cites W2516938750 @default.
• W2829754639 cites W2553231158 @default.
• W2829754639 cites W2558030739 @default.
• W2829754639 cites W2571905822 @default.
• W2829754639 cites W2587245385 @default.
• W2829754639 cites W2795155341 @default.
• W2829754639 cites W4235935369 @default.
• W2829754639 cites W89987640 @default.
• W2829754639 doi "https://doi.org/10.1186/s12879-018-3230-6" @default.
• W2829754639 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6042413" @default.
• W2829754639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29996783" @default.
• W2829754639 hasPublicationYear "2018" @default.
• W2829754639 type Work @default.
• W2829754639 sameAs 2829754639 @default.
• W2829754639 citedByCount "16" @default.
• W2829754639 countsByYear W28297546392019 @default.
• W2829754639 countsByYear W28297546392020 @default.
• W2829754639 countsByYear W28297546392021 @default.
• W2829754639 countsByYear W28297546392022 @default.
• W2829754639 countsByYear W28297546392023 @default.
• W2829754639 crossrefType "journal-article" @default.
• W2829754639 hasAuthorship W2829754639A5000612367 @default.
• W2829754639 hasAuthorship W2829754639A5001004624 @default.
• W2829754639 hasAuthorship W2829754639A5005030069 @default.
• W2829754639 hasAuthorship W2829754639A5007168352 @default.
• W2829754639 hasAuthorship W2829754639A5011647772 @default.
• W2829754639 hasAuthorship W2829754639A5014029759 @default.
• W2829754639 hasAuthorship W2829754639A5015001907 @default.
• W2829754639 hasAuthorship W2829754639A5019513252 @default.
• W2829754639 hasAuthorship W2829754639A5019623012 @default.
• W2829754639 hasAuthorship W2829754639A5028037547 @default.
• W2829754639 hasAuthorship W2829754639A5028536003 @default.
• W2829754639 hasAuthorship W2829754639A5046472072 @default.
• W2829754639 hasAuthorship W2829754639A5051379518 @default.
• W2829754639 hasAuthorship W2829754639A5062598432 @default.
• W2829754639 hasAuthorship W2829754639A5063041747 @default.
• W2829754639 hasAuthorship W2829754639A5066806599 @default.
• W2829754639 hasAuthorship W2829754639A5090307232 @default.
• W2829754639 hasBestOaLocation W28297546391 @default.
• W2829754639 hasConcept C120665830 @default.
• W2829754639 hasConcept C121332964 @default.
• W2829754639 hasConcept C126322002 @default.
• W2829754639 hasConcept C141071460 @default.
• W2829754639 hasConcept C142724271 @default.
• W2829754639 hasConcept C197934379 @default.
• W2829754639 hasConcept C2776228421 @default.

• next